| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$139,340 ) |
| | 2025 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM139619 | Temporal and Metabolic Regulation of Restimulation-Induced Cell Death (RICD) in Human T Cells | 000 | 4 | NIH | 11/4/2024 | $0 |
| | 2025 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AR081008 | Does joint lavage reduce intraarticular inflammation in high-energy tibial pilon fractures? | 000 | 3 | NIH | 10/25/2024 | $0 |
| | 2025 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21OD030163 | Advanced Image Analysis Tools for Super-Resolved MRI in Small Animals | 000 | 2 | NIH | 10/25/2024 | -$162 |
| | 2025 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI164407 | Role of primaquine pharmacokinetics in treatment efficacy for vivax malaria | 000 | 1 | NIH | 10/23/2024 | -$139,178 |
| | 2025 | 2022 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21CA257484 | Identifying EZH2-dependent vulnerabilities in RB deficient prostate cancer | 000 | 3 | NIH | 10/23/2024 | $0 |
|
| Issue Date FY: 2024 ( Subtotal = $17,148,817 ) (Continued on the next page) |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01NS119594 | Calcium Dysregulation and Cell Function in Spinal Muscular Atrophy | 001 | 4 | NIH | 4/18/2024 | $26,686 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS136126 | Inflammation and white matter microstructural alterations after OP exposure | 001 | 1 | NIH | 9/16/2024 | $0 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R35GM140792 | Regulation of cytoplasmic dynein in vivo | 000 | 4 | NIH | 8/15/2024 | $381,240 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AR081008 | Does joint lavage reduce intraarticular inflammation in high-energy tibial pilon fractures? | 000 | 3 | NIH | 7/19/2024 | $153,232 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 003 | 11 | NIH | 6/20/2024 | $134,429 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 003 | 11 | NIH | 6/20/2024 | $639,501 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI174937 | QALYs, Comorbidities, and Cost-effectiveness of HIV Care in the Department of Defense vs the Veterans Health Administration | 000 | 1 | NIH | 8/1/2024 | $156,251 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI135941 | Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | 005 | 7 | NIH | 8/14/2024 | $0 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21NS136126 | Inflammation and white matter microstructural alterations after OP exposure | 000 | 1 | NIH | 8/1/2024 | $254,408 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AA030041 | Leveraging genetic and electronic health record data to identify novel targets and drugs for treating alcohol use disorder | 002 | 3 | NIH | 7/12/2024 | -$8,339 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R03HD114176 | Quantifying Locomotor Outcomes with Agonist-Antagonist Myoneural Interface | 000 | 1 | NIH | 7/26/2024 | $240,722 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 004 | 11 | NIH | 7/2/2024 | $114,285 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21OD034471 | Identifying the radioprotective potential of radiation-resistant fungi using Drosophila | 000 | 1 | NIH | 7/25/2024 | $239,363 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI168295 | Mechanistic elucidation of pathogenic CBM complex mutations associated with atopic disease | 001 | 2 | NIH | 6/17/2024 | $708,492 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00NS112612 | The Mechanisms and Functional Consequences of Interhemispheric Plasticity | 000 | 4 | NIH | 6/25/2024 | $241,530 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI147627 | Plasmodium falciparum gametocytogenesis in vitro and in vivo | 001 | 5 | NIH | 5/21/2024 | $49,866 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals | 002 | 4 | NIH | 5/24/2024 | $82,571 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AA030041 | Leveraging genetic and electronic health record data to identify novel targets and drugs for treating alcohol use disorder | 000 | 3 | NIH | 6/10/2024 | $553,007 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI135941 | Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | 000 | 7 | NIH | 3/26/2024 | $898,170 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI176520 | Designing HIV-1 envelope immunogens to maximize neutralization breadth through use of multiple founder envelope antigens | 001 | 2 | NIH | 6/4/2024 | $880,838 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI135941 | Targeting HIV reservoirs in children with HIVIS DNA and MVA-CMDR vaccines | 001 | 7 | NIH | 5/17/2024 | $85,554 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01AI170033 | Mitigation of Radiation Induced Immune Dysfunction by PrC-210 Treatment | 000 | 3 | NIH | 5/8/2024 | $476,834 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI177698 | Maturation of human humoral immunity through repeat malaria challenges | 000 | 2 | NIH | 4/5/2024 | $788,047 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00HD099520 | Molecular analysis of MEHMO syndrome mutations in translation factor eIF2 | 001 | 4 | NIH | 5/6/2024 | $22,051 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 001 | 3 | NIH | 4/16/2024 | $17,443 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI155983 | Evaluation of Antibody Responses Elicited by Zika Vaccination in Flavivirus-naïve and -experienced Individuals | 001 | 4 | NIH | 2/28/2024 | $743,136 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01CA255232 | Isoform-specific signaling as a determinant of RAS-driven oncogenesis | 000 | 3 | NIH | 1/25/2024 | $313,951 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R00HD099520 | Molecular analysis of MEHMO syndrome mutations in translation factor eIF2 | 000 | 4 | NIH | 11/14/2023 | $220,513 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 002 | 11 | NIH | 11/2/2023 | $134,429 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | UM1AI108568 | United States Military HIV Research Program (MHRP) Clinical Trials Unit | 002 | 11 | NIH | 11/2/2023 | $639,502 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21CA267515 | Preventing Therapeutic Resistance in RAS-mutated Pediatric Cancers | 000 | 3 | NIH | 1/16/2024 | $164,671 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01AI147627 | Plasmodium falciparum gametocytogenesis in vitro and in vivo | 000 | 5 | NIH | 11/24/2023 | $448,809 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173635 | HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | 002 | 2 | NIH | 5/10/2024 | $18,983 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 002 | 3 | NIH | 6/25/2024 | $403,931 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01MH130197 | Impact of IL-15 immunotherapy on tissue-specific CD8 T cells to reduce the CNS HIV reservoir seeding and persistence | 002 | 3 | NIH | 6/25/2024 | $571,837 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173635 | HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | 000 | 2 | NIH | 10/24/2023 | $170,845 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173635 | HTLV-1 Replication/Reactivation-Induced DNA Damage: Mechanisms and Pathogenesis | 001 | 2 | NIH | 11/27/2023 | $0 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173847 | RNA and DNA sensors in the response of macrophages to ionizing radiation | 001 | 1 | NIH | 9/11/2024 | $23,936 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21AI173847 | RNA and DNA sensors in the response of macrophages to ionizing radiation | 000 | 1 | NIH | 5/14/2024 | $215,427 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | U01NS123252 | Antiglutamatergic Therapy to Protect the Brain Against Nerve Agents | 000 | 3 | NIH | 8/21/2024 | $735,815 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21MH132136 | Intrinsic CRF signaling within the lateral habenula | 001 | 2 | NIH | 8/14/2024 | $18,983 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R01HD114180 | Pluripotent stem cell-derived organoid model of human gonad development, functions, and disorders | 000 | 2 | NIH | 8/5/2024 | $578,218 |
| | 2024 | 2024 | THE HENRY M. JACKSON FOUNDATION FOR THE ADVANCEMENT OF MILITARY MEDICINE, INC. | 6720A ROCKLEDGE DR | BETHESDA | MD | 20817-1891 | MONTGOMERY | USA | R21MH132136 | Intrinsic CRF signaling within the lateral habenula | 000 | 2 | NIH | 2/27/2024 | $170,845 |
|
